Valuation: Terumo Corporation

Market Cap 3,790B 23.87B 20.44B 19.07B 17.5B 32.88B 2,284B 33.53B 226B 88.18B 1,145B 89.63B 87.68B P/E 2027 *
19.8x
P/E 2028 * 19.8x
Enterprise Value 3,844B 24.21B 20.73B 19.34B 17.75B 33.35B 2,317B 34.01B 229B 89.45B 1,161B 90.92B 88.94B EV / Sales 2027 *
3.06x
EV / Sales 2028 * 2.82x
Free-Float
97.07%
Yield 2027 *
1.45%
Yield 2028 * 1.58%
1 day-0.29%
1 week-1.97%
Current month+10.54%
1 month+13.30%
3 months+9.67%
6 months+30.94%
Current year+13.17%
1 week 2,404
Extreme 2404
2,689
1 month 2,133
Extreme 2133
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,746
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%-1.97%-7.07%+24.56% 23.94B
+1.65%+3.85%-12.47%+11.23% 198B
+0.82%+1.71%+1.90%+13.75% 118B
+1.40%+1.53%+5.08%+76.06% 60.05B
-1.37%-6.27%+28.79%+60.98% 53.18B
+1.70%+3.76%-3.22%-30.96% 51.11B
+1.03%+1.32%+12.79%-13.13% 34.05B
+3.48%-5.82% - - 28.58B
+0.36%+1.20%+45.75%-9.94% 24.9B
+0.99%+1.72%-4.12%+6.53% 22.98B
Average +0.98%-0.53%+7.49%+15.45% 61.44B
Weighted average by Cap. +1.11%+0.72%+1.27%+17.26%

Financials

2027 *2028 *
Net sales 1,256B 7.91B 6.77B 6.32B 5.8B 10.9B 757B 11.11B 74.97B 29.22B 379B 29.7B 29.06B 1,336B 8.42B 7.21B 6.72B 6.17B 11.59B 805B 11.82B 79.75B 31.09B 404B 31.6B 30.91B
Net income 189B 1.19B 1.02B 950M 871M 1.64B 114B 1.67B 11.27B 4.39B 57.01B 4.46B 4.37B 191B 1.2B 1.03B 962M 883M 1.66B 115B 1.69B 11.41B 4.45B 57.74B 4.52B 4.42B
Net Debt 54.63B 344M 295M 275M 252M 474M 32.93B 483M 3.26B 1.27B 16.5B 1.29B 1.26B -16.66B -105M -89.87M -83.85M -76.94M -145M -10.04B -147M -995M -388M -5.03B -394M -386M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
21/08/26 ¥2,569.00 -0.29% 4,562,800
20/08/26 ¥2,576.50 +4.23% 6,932,000
19/08/26 ¥2,472.00 -4.11% 9,014,900
18/08/26 ¥2,578.00 -1.60% 5,733,700
17/08/26 ¥2,620.00 -1.96% 3,448,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,576.50JPY
Average target price
3,133.08JPY
Spread / Average Target
+21.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock